Search research articles
Contact Us
Filters
Showing results (61-70 of 70) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 70 results.
Leukemia Research
|
September 10, 2015
BRAF<sup>V600E</sup> induces ABCB1/P-glycoprotein expression and drug resistance in B-cells via AP-1 activation
Yo-Ting Tsai, Gerard Lozanski, Amy Lehman, et al.
Journal of Neurosurgery
|
January 1, 2000
Temporal lobectomy in children: cognitive outcome
M Westerveld, K J Sass, G J Chelune, et al.
Annals of the New York Academy of Sciences
|
September 24, 1993
Neural transplantation for neurodegenerative diseases: past, present, and future
D E Redmond, R H Roth, D D Spencer, et al.
Blood
|
June 25, 2010
Milatuzumab immunoliposomes induce cell death in CLL by promoting accumulation of CD74 on the surface of B cells
Erin Hertlein, Georgia Triantafillou, Ellen J Sass, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 22, 2013
The proteasome inhibitor carfilzomib functions independently of p53 to induce cytotoxicity and an atypical NF-κB response in chronic lymphocytic leukemia cells
Sneha V Gupta, Erin Hertlein, Yanhui Lu, et al.
JCI Insight
|
August 9, 2021
Optimizing extracellular vesicles' isolation from chronic lymphocytic leukemia patient plasma and cell line supernatant
Sara Elgamal, Emanuele Cocucci, Ellen J Sass, et al.
Journal of Natural Products
|
December 17, 2016
Cardiac Glycoside Constituents of Streblus asper with Potential Antineoplastic Activity
Yulin Ren, Wei-Lun Chen, Daniel D Lantvit, et al.
Leukemia & Lymphoma
|
February 12, 2015
Phase I dose escalation trial of the novel proteasome inhibitor carfilzomib in patients with relapsed chronic lymphocytic leukemia and small lymphocytic lymphoma
Farrukh T Awan, Joseph M Flynn, Jeffrey A Jones, et al.
The AAPS Journal
|
May 4, 2011
Resistance to the translation initiation inhibitor silvestrol is mediated by ABCB1/P-glycoprotein overexpression in acute lymphoblastic leukemia cells
Sneha V Gupta, Ellen J Sass, Melanie E Davis, et al.
Blood Advances
|
January 4, 2018
BRAF<sup>V600E</sup> accelerates disease progression and enhances immune suppression in a mouse model of B-cell leukemia
Yo-Ting Tsai, Aparna Lakshmanan, Amy Lehman, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 70) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 70 results.
Leukemia Research
|
September 10, 2015
BRAF<sup>V600E</sup> induces ABCB1/P-glycoprotein expression and drug resistance in B-cells via AP-1 activation
Yo-Ting Tsai, Gerard Lozanski, Amy Lehman, et al.
Journal of Neurosurgery
|
January 1, 2000
Temporal lobectomy in children: cognitive outcome
M Westerveld, K J Sass, G J Chelune, et al.
Annals of the New York Academy of Sciences
|
September 24, 1993
Neural transplantation for neurodegenerative diseases: past, present, and future
D E Redmond, R H Roth, D D Spencer, et al.
Blood
|
June 25, 2010
Milatuzumab immunoliposomes induce cell death in CLL by promoting accumulation of CD74 on the surface of B cells
Erin Hertlein, Georgia Triantafillou, Ellen J Sass, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 22, 2013
The proteasome inhibitor carfilzomib functions independently of p53 to induce cytotoxicity and an atypical NF-κB response in chronic lymphocytic leukemia cells
Sneha V Gupta, Erin Hertlein, Yanhui Lu, et al.
JCI Insight
|
August 9, 2021
Optimizing extracellular vesicles' isolation from chronic lymphocytic leukemia patient plasma and cell line supernatant
Sara Elgamal, Emanuele Cocucci, Ellen J Sass, et al.
Journal of Natural Products
|
December 17, 2016
Cardiac Glycoside Constituents of Streblus asper with Potential Antineoplastic Activity
Yulin Ren, Wei-Lun Chen, Daniel D Lantvit, et al.
Leukemia & Lymphoma
|
February 12, 2015
Phase I dose escalation trial of the novel proteasome inhibitor carfilzomib in patients with relapsed chronic lymphocytic leukemia and small lymphocytic lymphoma
Farrukh T Awan, Joseph M Flynn, Jeffrey A Jones, et al.
The AAPS Journal
|
May 4, 2011
Resistance to the translation initiation inhibitor silvestrol is mediated by ABCB1/P-glycoprotein overexpression in acute lymphoblastic leukemia cells
Sneha V Gupta, Ellen J Sass, Melanie E Davis, et al.
Blood Advances
|
January 4, 2018
BRAF<sup>V600E</sup> accelerates disease progression and enhances immune suppression in a mouse model of B-cell leukemia
Yo-Ting Tsai, Aparna Lakshmanan, Amy Lehman, et al.
Page
of 7